Grading of Frozen Shoulder
Frozen shoulder is graded using a three-stage clinical classification system based on duration and severity: Stage 1 ("Freezing") lasting 4-6 months with progressive pain and motion loss, Stage 2 ("Frozen") lasting 4-6 months with persistent stiffness but improving pain, and Stage 3 ("Thawing") lasting 4-6 months with gradual return of motion. 1
Clinical Staging System
The most widely accepted grading system divides frozen shoulder into three distinct phases, each typically lasting 4-6 months 1:
Stage 1: Freezing (Painful Phase)
- Duration: 4-6 months
- Key Features:
- Progressive loss of passive range of motion (ROM)
- Worsening pain, particularly at night
- Pain with all shoulder movements
- Increasing functional limitation
- Clinical Findings: Shoulder continuously loses passive motion with inflammatory pain predominating 1
Stage 2: Frozen (Adhesive/Stiffening Phase)
- Duration: 4-6 months
- Key Features:
- Continued significant stiffness
- Improvement in pain and inflammation
- Plateau of motion restriction
- Global restriction of passive glenohumeral motion in all planes 2
- Clinical Findings: Maximum restriction of both active and passive ROM, but pain begins to subside 1
Stage 3: Thawing (Recovery Phase)
- Duration: 4-6 months (can extend to 12-18 months total)
- Key Features:
- Gradual improvement in ROM
- Decreasing restriction of shoulder motion
- Minimal to no pain
- Progressive functional recovery
- Clinical Findings: Spontaneous improvement in motion, though full pain-free range may not be restored in everyone 3
Severity Assessment Based on Motion Loss
Diagnostic criteria require significant reduction in both active and passive ROM 1. The most commonly assessed movements include:
- Flexion: Loss of forward elevation
- Abduction: Loss of lateral elevation
- External rotation: Most sensitive indicator, often the first and last motion affected 4
- Internal rotation: Assessed by hand-behind-back positioning
Most studies require loss in at least 2-3 planes of motion (commonly flexion, abduction, and external rotation), though quantitative cutoffs vary widely across clinical trials 5. External rotation restriction correlates strongly with disease severity and intra-articular pathology 6.
Additional Severity Indicators
Glenohumeral Adduction Restriction (AR)
Recent evidence identifies adduction restriction as a predictor of intra-articular lesion severity 6:
- Freezing phase: AR present in 37.5% of patients
- Frozen phase: AR present in 85.7% of patients
- Correlation: AR severity increases from freezing to frozen phase and correlates with external rotation loss
- Clinical significance: Presence of AR prolongs treatment duration and increases need for manipulation 6
Important Clinical Caveats
The traditional 4-6 month duration for each stage is not constant and varies with interventions 7. Total symptom duration typically ranges from 12-18 months with conservative treatment, though some patients experience prolonged symptoms beyond this timeframe 7, 2.
Pain severity at baseline predicts treatment response: Patients with higher baseline pain (measured by VAS) tend to experience greater improvements in shoulder function following treatment 8.
Stage-specific treatment is essential: Treatment should be adjusted to the clinical stage, with analgesics and injections prioritized in Stage 1, and physiotherapy with manual therapy emphasized in Stages 2 and 3 1.
The diagnosis remains primarily clinical, based on characteristic history and examination demonstrating global passive motion restriction, with imaging reserved for excluding alternative shoulder pathology 2.